Invesco Ltd. cut its holdings in shares of Global Medical REIT Inc. (NYSE:GMRE - Free Report) by 15.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,229,075 shares of the company's stock after selling 226,214 shares during the period. Invesco Ltd. owned about 1.84% of Global Medical REIT worth $9,488,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of GMRE. Commonwealth Equity Services LLC lifted its position in shares of Global Medical REIT by 16.8% during the fourth quarter. Commonwealth Equity Services LLC now owns 12,646 shares of the company's stock worth $98,000 after purchasing an additional 1,819 shares in the last quarter. PNC Financial Services Group Inc. raised its position in Global Medical REIT by 58.1% in the 4th quarter. PNC Financial Services Group Inc. now owns 6,260 shares of the company's stock worth $48,000 after purchasing an additional 2,301 shares during the last quarter. Rhumbline Advisers lifted its holdings in Global Medical REIT by 2.6% during the 4th quarter. Rhumbline Advisers now owns 108,862 shares of the company's stock worth $840,000 after buying an additional 2,731 shares in the last quarter. New York State Common Retirement Fund boosted its position in Global Medical REIT by 3.2% in the 4th quarter. New York State Common Retirement Fund now owns 94,158 shares of the company's stock valued at $727,000 after buying an additional 2,900 shares during the last quarter. Finally, SG Americas Securities LLC increased its stake in shares of Global Medical REIT by 13.8% in the 4th quarter. SG Americas Securities LLC now owns 25,828 shares of the company's stock valued at $199,000 after buying an additional 3,128 shares during the period. 57.52% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Separately, B. Riley began coverage on Global Medical REIT in a research note on Thursday, April 3rd. They set a "neutral" rating and a $9.00 price target on the stock.
View Our Latest Report on GMRE
Global Medical REIT Trading Up 0.1 %
Shares of GMRE traded up $0.01 on Friday, reaching $7.68. 258,177 shares of the company's stock were exchanged, compared to its average volume of 446,472. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 1.26. The stock has a market capitalization of $513.57 million, a P/E ratio of -383.81, a price-to-earnings-growth ratio of 1.43 and a beta of 1.12. The business has a 50 day moving average price of $8.20 and a two-hundred day moving average price of $8.36. Global Medical REIT Inc. has a 12 month low of $6.75 and a 12 month high of $10.46.
Global Medical REIT (NYSE:GMRE - Get Free Report) last released its earnings results on Thursday, February 27th. The company reported $0.22 EPS for the quarter, topping analysts' consensus estimates of $0.01 by $0.21. The firm had revenue of $35.16 million during the quarter, compared to analyst estimates of $34.87 million. Global Medical REIT had a net margin of 3.23% and a return on equity of 0.86%. Research analysts anticipate that Global Medical REIT Inc. will post 0.81 earnings per share for the current year.
Global Medical REIT Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, April 9th. Shareholders of record on Friday, March 21st were paid a $0.21 dividend. This represents a $0.84 annualized dividend and a yield of 10.94%. The ex-dividend date of this dividend was Friday, March 21st. Global Medical REIT's payout ratio is 8,400.00%.
About Global Medical REIT
(
Free Report)
Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Recommended Stories

Before you consider Global Medical REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.
While Global Medical REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.